Antibacterial protein
US6063765A · kind A · utility
3Cited by
0References
19Claims
0Family size
Inventors
Key dates
| Filing date | Jan 28, 1998 |
| Grant date | May 16, 2000 |
| Priority date | — |
| Expiry date | Jan 28, 2018 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a novel antibacterial protein, called gloverin. Preferably, gloverin is isolated from Hyalophora moths. Alternatively, gloverin is produced by genetic engineering or by chemical synthesis. Also, the invention relates to pharmaceutical compositions comprising gloverin or pharmaceutically active fragments thereof and use of gloverin or fragments thereof as a medicament against bacterial infection. Furthermore, the invention relates to a method of treating bacterial infection comprising administration of gloverin or pharmaceutically active fragments thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.